Evaluations of Bristol-Myers-Squibb-funded diabetes education and intervention efforts in five underserved communities showed improved clinical outcomes for participants.
Evaluations of Bristol-Myers-Squibb-funded diabetes education and intervention efforts in five underserved communities showed improved clinical outcomes for participants.